Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 11 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AvT PHARMA from Affligem, company number BE1004935935, closed financial year 2025 with a result of € 48,207 after tax. For that financial year AvT PHARMA recorded a gross margin of € 88,022 and equity of € 134,018. Compared with financial year 2024, the result moved from € 35,812 to € 48,207. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 134,018
▲ 56% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 48,207
▲ 35% vs 2024
Profit after tax over the fiscal year.
€ 25,514
▼ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 84,018.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 1,741
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 367,057
▼ 13% vs 2024
€ 106,811 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 1,537
▼ 61% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,870
▲ 165% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 70,639 | € 88,022 | ▲ 25% |
| Profit after taxes | € 35,812 | € 48,207 | ▲ 35% |
| Equity | € 85,812 | € 134,018 | ▲ 56% |
| Total debts | € 600,839 | € 547,912 | ▼ 9% |
| Cash | € 33,692 | € 25,514 | ▼ 24% |
| Retained profit | € 35,812 | € 84,018 | ▲ 135% |
| Bank debt | € 422,773 | € 367,057 | ▼ 13% |
| Balance sheet total | € 686,651 | € 681,930 | ▼ 1% |
Key figures of AvT PHARMA, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AvT PHARMA?
What happened at AvT PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 48,207 (▲ 35% vs 2024). Source: NBB ↗
- New establishment in Affligem. KBO
- ANN VAN TICHELEN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 35,812 profit in 2024 to € 48,207 profit in 2025.
Paid € 39,965 in corporate taxes since 2024.
Best year ever: 2025, with € 48,207 profit.
A new publication or filing at AvT PHARMA? We notify you, reason included.
Follow AvT PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AvT PHARMA is ANN VAN TICHELEN. ANN VAN TICHELEN is also behind APOTHEEK LIBENS-VAN TICHELEN.
Directors
According to the 2025 annual accounts
since 2024
Establishments
Establishment units
Physical locations of this company
Brusselbaan 134
1790 Affligem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1004.935.935
- VAT number
- BE 1004.935.935
- Registered office
- Brusselbaan 134, 1790 Affligem
- Names & denominations
- AvT PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2024
- Peppol
- Active · Active since 27 Jun 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Activiteiten van hoofdkantoren
Overige dienstverlenende activiteiten op het gebied van informatie
Overige zakelijke dienstverlening, neg
Holdings
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.